James A. Daniel

Max-Planck-Institute for Experimental Medicine, Göttingen, Germany 
Synaptic transmission, dopamine, endocytosis
"James Daniel"
Mean distance: 53433
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Daniel JA, Chau N, Abdel-Hamid MK, et al. (2015) Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis. Traffic (Copenhagen, Denmark). 16: 635-54
Daniel JA, Robinson PJ. (2014) Rapid analysis of synaptic vesicle endocytosis in synaptosomes Neuromethods. 83: 167-189
McCluskey A, Daniel JA, Hadzic G, et al. (2013) Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. Traffic (Copenhagen, Denmark). 14: 1272-89
McGeachie AB, Odell LR, Quan A, et al. (2013) Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors. Acs Chemical Biology. 8: 1507-18
Daniel JA, Malladi CS, Kettle E, et al. (2012) Analysis of synaptic vesicle endocytosis in synaptosomes by high-content screening. Nature Protocols. 7: 1439-55
Galbraith S, Daniel JA, Vissel B. (2010) A study of clustered data and approaches to its analysis Journal of Neuroscience. 30: 10601-10608
Odell LR, Howan D, Gordon CP, et al. (2010) The pthaladyns: GTP competitive inhibitors of dynamin I and II GTPase derived from virtual screening. Journal of Medicinal Chemistry. 53: 5267-80
Hill TA, Mariana A, Gordon CP, et al. (2010) Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis. Journal of Medicinal Chemistry. 53: 4094-102
Daniel JA, Galbraith S, Iacovitti L, et al. (2009) Functional heterogeneity at dopamine release sites Journal of Neuroscience. 29: 14670-14680
See more...